ONC
BeOne Medicines Ltd.Company with tickers: ONC, BEIGF
CIK
1651308
CUSIP
07725L102
Shares Outstanding
94,900,812
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,513,438,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | $1,346,223,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Expenses | — | ||||
| Research & Development | $541,224,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $249,902,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $227,357,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $0.16 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $0.15 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |